Bandingkan Harga & Kinerja Pancaran Samudera Transport Tbk. (PSAT) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Pancaran Samudera Transport Tbk. dan Organon Pharma Indonesia Tbk.: Pancaran Samudera Transport Tbk. diperdagangkan di Rp880 (kapitalisasi pasar 1,32 T, volume 24 jam 51,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pancaran Samudera Transport Tbk. jauh lebih besar — sekitar 12,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PSAT | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,32 T | 104,4 M |
Volume | 51,1 rb | — |
Lot | 511 | — |
Perputaran | 45,29 jt | — |
Harga Rata-rata | 886,35 | — |
Nilai Transaksi | 45,29 jt | — |
Harga Ekuilibrium Indikatif | 880 | — |
Volume Ekuilibrium Indikatif | 5 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Pancaran Samudera Transport Tbk.
PT Pancaran Samudera Transport Tbk (the Company) was established on December 10, 2007 in the Republic of Indonesia based on the Notarial Deed No. 1 from Mary Maria, S.H, Notary in Depok. The Company commenced its operations in 2007. The Companys immediate parent company is PT Profitama Hasil Indah, incorporated and domiciled in Indonesia and its ultimate parent company is PT Pancaran Harapan Integra, also incorporated and domiciled in Indonesia.
Selengkapnya di halaman PSAT →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
